Biogen, Novartis, Teva involved in major kickback controversy with US Medicare


Source: MercoPress


A Florida-based charity will pay US$4 million to resolve claims that it acted as a conduit for companies including Biogen Inc and Novartis AG to pay kickbacks to Medicare patients using their high-priced multiple sclerosis drugs, the U.S. Justice Department said on Wednesday.

The settlement with the patient assistance charity The Assistance Fund marked the third so far with a foundation linked to an industry-wide probe that has resulted in US$850 million in settlements with drug makers and charities.

TAF like the other foundations provide assistance to patients seeking to pay out-of-pocket costs for medications and says that since 2009 it has provided assistance to 78,000 people.



Cont'd.

LINK:
https://en.mercopress.com/2019/11/21/biogen-novartis-teva-involved-in-major-kickback-controversy-with-us-medicare

Discusiones sobre el mismo tema

URL de retroenlace : https://www.ictal.org/index.php?trackback/1777

Fuente de los comentarios de esta entrada